Free Trial

Akebia Therapeutics (AKBA) SEC Filings & 10K Form

Akebia Therapeutics logo
$3.60 -0.03 (-0.69%)
Closing price 07/3/2025 02:45 PM Eastern
Extended Trading
$3.62 +0.01 (+0.28%)
As of 07/3/2025 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Akebia Therapeutics SEC Filings

DateFilerForm TypeView
06/30/2025
4:46 PM
Akebia Therapeutics (Subject)
Ostrowski Erik (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2025
6:21 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
4:13 PM
Akebia Therapeutics (Issuer)
Malabre Richard C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:13 PM
Akebia Therapeutics (Issuer)
FRIESON RON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:14 PM
Akebia Therapeutics (Issuer)
GILMAN STEVEN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:14 PM
Akebia Therapeutics (Issuer)
ROGERS MICHAEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:15 PM
Akebia Therapeutics (Issuer)
Smith Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:15 PM
Akebia Therapeutics (Issuer)
Wolf Myles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:16 PM
ADAMS ADRIAN (Reporting)
Akebia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:16 PM
Akebia Therapeutics (Issuer)
ZUMWALT LEANNE M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
6:04 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
6:29 AM
Akebia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/20/2025
3:44 PM
Akebia Therapeutics (Filer)
Form 424B5
03/20/2025
3:48 PM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2025
3:12 PM
Akebia Therapeutics (Filer)
Form 424B5
03/13/2025
6:27 AM
Akebia Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2025
6:08 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
4:05 PM
Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
4:39 PM
Akebia Therapeutics (Subject)
Burke Steven Keith (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
4:37 PM
Akebia Therapeutics (Subject)
Butler John P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/07/2025
7:16 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
4:48 PM
Akebia Therapeutics (Issuer)
Ostrowski Erik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:51 PM
Akebia Therapeutics (Issuer)
Grund Nicholas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:52 PM
Akebia Therapeutics (Issuer)
Malabre Richard C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:53 PM
Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:54 PM
Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
4:50 PM
Akebia Therapeutics (Subject)
Butler John P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
4:58 PM
Akebia Therapeutics (Subject)
Burke Steven Keith (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
5:02 PM
Akebia Therapeutics (Subject)
Grund Nicholas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2025
6:40 AM
Akebia Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/13/2025
7:05 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:05 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:16 AM
Akebia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/22/2024
5:06 PM
Akebia Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
10/22/2024
7:05 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
6:36 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
11:15 PM
Akebia Therapeutics (Filer)
Form EFFECT
08/08/2024
6:52 AM
Akebia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:06 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2024
5:05 AM
Akebia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AKBA) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners